Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study.
Quintana-Castanedo L, Sánchez-Ramón S, Maseda R, Illera N, Pérez-Conde I, Molero-Luis M, Butta N, Arias-Salgado EG, Monzón-Manzano E, Zuluaga P, Martínez-Santamaría L, Fernández-Arquero M, Llames SG, Meana Á, de Lucas R, Del Río M, Vicente Á, Escámez MJ, Sacedón R.
Quintana-Castanedo L, et al. Among authors: de lucas r.
Exp Dermatol. 2024 Aug;33(8):e15146. doi: 10.1111/exd.15146.
Exp Dermatol. 2024.
PMID: 39075828
Free PMC article.